Status:
RECRUITING
Cardiac Hemodynamics During Left Ventricular Assist
Lead Sponsor:
Region Östergötland
Collaborating Sponsors:
Linkoeping University
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to exploratively investigate intracardiac geometry and hemodynamics in patients with ongoing HeartMate 3-therapy in the Swedish Southeast Healthcare region. The...
Detailed Description
1. BACKGROUND In recent years, the use of the mechanical circulatory support device, HeartMate 3 (HM3) (Abbott Laboratories, Lake Forest, IL), has garnered significant attention in the realm of ci...
Eligibility Criteria
Inclusion
- Connected to Linköping University Hospital ((situated in the Swedish Southeastern healthcare region)
- Treatment with HeartMate 3 and implanted for \> 6 months ago
- Age \>18 years.
Exclusion
- Reduced kidney function (eGFR below 45 ml/min/1.73m2).
- Known iodine contrast allergy
- In case of untreated manifest hyperthyroidism
- In case of suspected/newly diagnosed thyroid cancer where radioiodine examination/treatment may be relevant
- Myasthenia Gravis
- Ongoing pregnancy
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06115096
Start Date
March 1 2023
End Date
January 1 2030
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Linköping University Hospital
Linköping, Östergötland County, Sweden, 58185